• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

Leading South African COVID scientist accuses West of racism over skeptical response to country’s Omicron research

By
David Meyer
David Meyer
Down Arrow Button Icon
By
David Meyer
David Meyer
Down Arrow Button Icon
January 21, 2022, 8:15 AM ET

A senior South African scientist has accused Western nations of racism, over the way they skeptically received early data from the country showing that the Omicron variant of the novel coronavirus is relatively mild.

Shabir Madhi—professor of vaccinology at the University of the Witwatersrand, chair of the National Advisory Group on Immunization, and a top World Health Organization adviser—told the BBC that the West had at the least refused “to believe the science because it came from Africa.”

“It seems like high-income countries are much more able to absorb bad news that comes from countries like South Africa,” he said. “When we’re providing good news, all of a sudden there’s a whole lot of skepticism. I would call that racism.”

Madhi was one of the prominent South African experts telling the world in early December that Omicron was fast-spreading but had what seemed to be a low hospitalization rate. The country’s scientists continued to emit such data throughout that month, before a formal South African study—and two others from the U.K.—confirmed Omicron’s mildness. Within a couple weeks, rich countries’ leaders started talking about treating Omicron like the flu, though the WHO continues to warn against being so blasé about the variant.

Some of the early skepticism referenced the potentially confounding effects of South Africa’s relatively young population; younger people are generally less likely to get serious ill with COVID. However, Madhi pointed out that South Africans are actually more susceptible to severe disease, because of the prevalence of HIV and high obesity rates there. (Indeed, South African scientists were noting from the start that Omicron was having a milder impact on older people as well as younger.)

“Scientifically rigorous”

Salim Karim, the South African vice-president of the International Science Council, also told the BBC that “everyone was expecting the worst [about Omicron] and when they weren’t seeing it, they were questioning whether our observations were sufficiently scientifically rigorous.”

As it happens, South Africa has excellent laboratory infrastructure, largely thanks to the decades it has spent fighting HIV and tuberculosis, among other viruses and diseases.

A few months after the pandemic struck, the government tapped into this infrastructure by establishing a new network of labs, scientists and academics to sequence samples and provide scientific data in the COVID-19 fightback. A Regional Centre of Excellence for Genomic Surveillance and Bioinformatics was set up last July, to support the rapid expansion of sequencing across the whole of southern Africa.

African COVID vaccine production is already leaning heavily on South Africa, due to the advanced state of its biotech sector, though more capacity is likely to come online in Senegal this year.

South Africa’s genomic-sequencing prowess has certainly proved useful. It identified the Beta variant in late 2020 and Omicron a year later, after scientists there and in neighboring Botswana discovered the new strain at the same time. (Botswanan President Mokgweetsi Masisi subsequently said his country’s first cases were foreign diplomats who had come from Europe.)

“Vaccine apartheid”

But the reaction to these discoveries also prompted rich countries to institute travel bans on the region, decimating tourism and hammering currencies. This reaction was widely characterized as racist—and ineffective.

“When South African scientists discovered Omicron, the new variant, they immediately took on the responsibility of informing the entire world that a new variant has been found,” President Cyril Ramaphosa said last month. “And what was the response? The northern countries decided to punish the excellence from Africa. They basically said, we will not allow you to travel. Lo and behold! Omicron is spreading all over the world.”

The South African leader also slammed rich countries over their hoarding of vaccines, claiming they were fueling “vaccine apartheid”—a reference to the racist system of “separate development” that heavily oppressed South African Black people in the days of white minority rule.

“They are just giving us the crumbs from their table. The greed they demonstrated was disappointing, particularly when they say they are our partners. Because our lives in Africa are just as important as lives in Europe, North America and all over,” Ramaphosa said.

Never miss a story: Follow your favorite topics and authors to get a personalized email with the journalism that matters most to you.

About the Author
By David Meyer
LinkedIn icon
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Most Popular

placeholder alt text
North America
'I meant what I said in Davos': Carney says he really is planning a Canada split with the U.S. along with 12 new trade deals
By Rob Gillies and The Associated PressJanuary 28, 2026
2 days ago
placeholder alt text
Politics
The American taxpayer spent nearly half a billion dollars deploying federal troops to U.S. cities in 2025, CBO finds
By Nick LichtenbergJanuary 28, 2026
2 days ago
placeholder alt text
C-Suite
Jeff Bezos capped his Amazon salary at $80,000: ‘How could I possibly need more incentive?’
By Sydney LakeJanuary 28, 2026
2 days ago
placeholder alt text
C-Suite
Coins2Day 500 CEOs are no longer giving employees an A for effort. Now they want proof of impact
By Claire ZillmanJanuary 28, 2026
3 days ago
placeholder alt text
Investing
Jerome Powell got a direct question about the U.S. ‘losing credibility’ and the soaring price of gold and silver. He punted
By Eva RoytburgJanuary 29, 2026
1 day ago
placeholder alt text
Personal Finance
Current price of silver as of Thursday, January 29, 2026
By Joseph HostetlerJanuary 29, 2026
1 day ago

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Latest in Health

Healthoutdoor and sporting goods
5 Best Sauna Blankets of 2026: Tested by Recovery Experts
By Christina SnyderJanuary 30, 2026
4 hours ago
A person laying on a bed in a store.
Healthmattresses
How to Choose a Mattress: The Ultimate Guide
By Jessica RendallJanuary 30, 2026
7 hours ago
HealthScience
As billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial
By Marco Quiroz-GutierrezJanuary 30, 2026
11 hours ago
C-SuiteCoins2Day 500: Titans and Disruptors of Industry
Pfizer CEO says he used ‘emotional blackmail’ to get employees to achieve impossible goals during COVID-19
By Eva RoytburgJanuary 29, 2026
20 hours ago
man
HealthHealth
Life is actually getting better—and longer—for Americans, despite everything you read in the news
By Mike Stobbe and The Associated PressJanuary 29, 2026
24 hours ago
A pile of different-sized mattresses.
Healthmattresses
A Guide to All Mattress Dimensions: How to Choose the Right Size Bed
By Jessica RendallJanuary 29, 2026
1 day ago